The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome
NCT04912934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 214
Last updated 2021-06-03
Summary
The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects.
Conditions
- Metabolic Syndrome
- Emotional Eating
- COVID-19
Interventions
- PROCEDURE
-
A survey form was applied to individuals included in the study face-to-face.
This study was completed with a descriptive, cross-sectional and relational screening model
Sponsors & Collaborators
-
T.C. ORDU ÜNİVERSİTESİ
lead OTHER
Principal Investigators
-
Dilek Küçük Alemdar · T.C. ORDU ÜNİVERSİTESİ
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-20
- Primary Completion
- 2020-11-20
- Completion
- 2020-12-12
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Impact of the Mediterranean Diet on Anthropometric Indices, Lipid Profiles, Energy Metabolism Signaling Proteins and Inflammatory Cytokines in Psychiatric Patients With Metabolic Syndrome
NCT07164014 ·Status: COMPLETED ·Phase: NA
-
Endogenous Opioid Activity and Affective State in Insulin Resistant Women
NCT02069379 ·Status: COMPLETED ·Phase: PHASE4
-
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
NCT00617240 ·Status: COMPLETED ·Phase: PHASE2
-
Glycemic Index/ Load and Mental Disorders
NCT02362113 ·Status: UNKNOWN
-
Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics
NCT00845936 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction
NCT00895570 ·Status: COMPLETED ·Phase: NA
-
Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)
NCT04543253 ·Status: RECRUITING
-
An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
NCT00448630 ·Status: COMPLETED
-
Olfactory Odour Stimulation for Metabolism Control
NCT04223284 ·Status: COMPLETED ·Phase: NA
-
Steroid and Behaviour Changes Under Metformin
NCT04930471 ·Status: UNKNOWN
-
A New Supplement for the "Metabolic Syndrome"
NCT03813914 ·Status: COMPLETED ·Phase: NA
-
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
NCT05744479 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Herbal Products on Metabolism and Hunger
NCT00198952 ·Status: COMPLETED ·Phase: NA
-
Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome
NCT03271866 ·Status: UNKNOWN ·Phase: NA
-
The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity
NCT01384279 ·Status: COMPLETED ·Phase: NA
-
Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time
NCT00809536 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing
NCT04420000 ·Status: COMPLETED ·Phase: NA
-
Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
NCT03817840 ·Status: COMPLETED
-
Metformin for Treatment of Antipsychotic-induced Dyslipidemia
NCT01778244 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake
NCT06556277 ·Status: COMPLETED ·Phase: NA
-
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
NCT00816907 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea
NCT01423487 ·Status: WITHDRAWN ·Phase: NA
-
Effects of LDX on Cognitive Processes and Appetite
NCT04181957 ·Status: TERMINATED ·Phase: NA
-
Short-term Metabolic Effects of Mirtazapine in Healthy Subjects
NCT00878540 ·Status: COMPLETED ·Phase: PHASE1
-
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
NCT07212075 ·Status: RECRUITING